Olmesartan-induced enteropathy

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Olmesartan and Drug-Induced Enteropathy

Dr. Tran is Assistant Clinical Professor at St. John’s University and Clinical Pharmacy Manager at New York–Presbyterian Hospital/ Columbia University Medical Center in New York City. Hanlin Li is a fi nal-year doctor of pharmacy candidate at St. John’s University College of Pharmacy and Health Sciences, in Jamaica, New York. She is also a pharmacy intern at New York–Presbyterian Hospital–Weill...

متن کامل

Olmesartan-Induced Sprue Like Enteropathy

Chronic diarrhoea is a common clinical problem in gastroenterology practice and often it is difficult to diagnose the cause. Villous atrophy is not specific and the rarer possibility of drug-induced enteritis should always be considered. Olmesartan has recently been described as a cause of drug-induced enteropathy characterized by chronic diarrhoea and varying degrees of duodenal mucosa atrophy...

متن کامل

Olmesartan Enteropathy

Celiac disease is an immune-mediated small intestinal mucosal disorder with characteristic, but nonspecific histopathological changes. A number of heterogeneous disorders may produce similar changes in small bowel biopsies, but these fail to respond to a gluten-free diet. Recently, it has become increasingly appreciated that different medications may cause this sprue-like intestinal disease, in...

متن کامل

Rare Case of Olmesartan Induced Enteropathy

HANDA R, RAHMAN A, VIVEK K. A Rare Case of Olmesartan-Induced Enteropathy. Spartan Med. Res. J. Vol. 2, No. 2, pp. 29-37, 2017. CONTEXT: Olmesartan (brand name Benicar) is an antihypertensive drug clinicians commonly use to treat high blood pressure. Olmesartan induced enteropathy (OSE) is a rare entity that authors first identified in 2012. The etiological basis of OSE remains unclear, althoug...

متن کامل

Enteropathy Associated with Olmesartan

The recognition of an enteropathy caused by olmesartan is recent. It was first described in 2012 by the Mayo Clinic, which presented 22 clinical cases. Olmesartan is a highly prescribed drug and the differential diagnosis of a sprue-like enteropathy is very wide, so it is important to be aware of this pathology. We report a case of a 67-years-old man, with arterial hypertension under treatment ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: BMJ Case Reports

سال: 2018

ISSN: 1757-790X

DOI: 10.1136/bcr-2018-224411